Amended Statement of Beneficial Ownership (3/a)
18 Juin 2015 - 12:10AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Theoharis Chris
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/11/2007
|
3. Issuer Name
and
Ticker or Trading Symbol
MANHATTAN SCIENTIFICS INC [MHTX]
|
(Last)
(First)
(Middle)
405 LEXINGTON AVENUE, 26TH FLOOR
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
NEW YORK, NY 10174
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
10/24/2007
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
4011260
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Warrant
|
10/11/2007
|
10/11/2017
|
Common Stock
|
800000
|
$0.013
|
D
|
|
Explanation of Responses:
|
Remarks:
This amendment has been filed to correct an error in the number of shares of common stock held by Mr. Theoharis which was overstated by 199,240.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Theoharis Chris
405 LEXINGTON AVENUE
26TH FLOOR
NEW YORK, NY 10174
|
|
|
|
|
Signatures
|
/s/ Chris Theoharis
|
|
6/17/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Manhattan Scientifics (PK) (USOTC:MHTX)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Manhattan Scientifics (PK) (USOTC:MHTX)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Manhattan Scientifics Inc (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Manhattan Scientifics Inc